Patents by Inventor Stephen Bryan

Stephen Bryan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7745630
    Abstract: Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Z, O, A, V, Y and Y? are as defined herein; are useful for treating dysmenorreah.
    Type: Grant
    Filed: December 10, 2004
    Date of Patent: June 29, 2010
    Inventors: Justin Stephen Bryans, Patrick Stephen Johnson, Lee Richard Roberts, Thomas Ryckmans
  • Publication number: 20100152941
    Abstract: A system and method for determining and displaying an overall efficiency value of a vehicle. The vehicle may include an engine and an electric machine that operates to provide torque to propel the vehicle. In addition, the vehicle may have an electric power source that provides electric power to the electric machine. A controller may determine and transmit the overall efficiency value so that the information display displays the number of efficiency indicators. Also, the number of efficiency indicators displayed may be based on the overall efficiency value.
    Type: Application
    Filed: February 24, 2010
    Publication date: June 17, 2010
    Applicant: FORD GLOBAL TECHNOLOGIES, LLC
    Inventors: Ryan J. Skaff, Robert Jay Louch, Anthony Howard, Stephen Burke, David Watson, Angela L. Watson, Derek Hartl, Paul Stephen Bryan
  • Publication number: 20100106352
    Abstract: A system and method for determining and displaying an overall efficiency value of a vehicle. The vehicle may include an engine and an electric machine that operates to provide torque to propel the vehicle. In addition, the vehicle may have an electric power source that provides electric power to the electric machine. A controller may determine and transmit the overall efficiency value so that the information display displays the number of efficiency indicators. Also, the number of efficiency indicators displayed may be based on the overall efficiency value.
    Type: Application
    Filed: October 28, 2008
    Publication date: April 29, 2010
    Applicant: FORD GLOBAL TECHNOLOGIES, LLC
    Inventors: Ryan J. Skaff, Robert Jay Louch, Anthony Howard, Stephen Burke, David Watson, Angela L. Watson, Derek Hartl, Paul Stephen Bryan
  • Publication number: 20100056524
    Abstract: A first aspect of the invention relates to a compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, wherein: R1 is C3-8-cycloalkyl; X is O, NR7 or C3-6-heterocycloalkyl; R2 is aryl, heteroaryl, fused or unfused aryl-C3-6-heterocycloalkyl or fused or unfused heteroaryl-C3-6-heterocycloalkyl, each of which is optionally substituted by one or more substitutents selected from aryl, heteroaryl, C1-6-alkyl, C3-7-cycloalkyl and a group A, wherein said C1-6-alkyl group is optionally substituted by one or more substituents selected from aryl, heteroaryl, R10 and a group A, said heteroaryl group is optionally substituted by one or more R10 groups; and wherein said C3-6-heterocycloalkyl group optionally contains one or more groups selected from oxygen, sulfur, nitrogen and CO; R3 is C1-6-alkyl optionally substituted by one or more substituents selected from aryl, heteroaryl, —NR4R5, —OR6, —NR7(CO)R6, —NR7(CO)NR4R5, —NR7SO2R6, —NR7COOR7, —CONR4R5, C3-6-heterocycloalkyl and wherein R4
    Type: Application
    Filed: April 2, 2009
    Publication date: March 4, 2010
    Inventors: Edward Giles Mciver, Justin Stephen Bryans, Ela Smiljanic, Stephen John Lewis, Joanne Hough, Thomas Drake
  • Publication number: 20100023194
    Abstract: A method for controlling a powertrain for a hybrid electric vehicle having an engine and a motor and gearing for establishing power flow paths from the engine and the motor with common gear elements to vehicle traction wheels. An engine power bias is applied to an engine power command and a bias to a motor torque command to avoid an operating mode in which motor torque is at or near zero, whereby gear rattle due to torque disturbances is avoided.
    Type: Application
    Filed: July 22, 2009
    Publication date: January 28, 2010
    Applicant: FORD GLOBAL TECHNOLOGIES, LLC
    Inventors: Carol Louise Okubo, David Jason Mack, Melinda A. Mack, Paul Stephen Bryan
  • Publication number: 20090210108
    Abstract: A control strategy is disclosed for regulating speed of an engine in a hybrid electric vehicle powertrain that includes an electric motor and gearing. An electrical power flow path and a mechanical power flow path are established. Electrical power is coordinated with mechanical power to effect an arbitrated engine speed for a given power demand that will result in an acceptable noise, vibration and harshness (NVH) characteristic for the powertrain and an acceptable powertrain efficiency.
    Type: Application
    Filed: February 15, 2008
    Publication date: August 20, 2009
    Applicant: FORD GLOBAL TECHNOLOGIES, LLC
    Inventors: Shunsuke Okubo, Paul Stephen Bryan
  • Publication number: 20090140521
    Abstract: The method of the invention controls engine speed during engine starting for a hybrid electric vehicle that includes a battery, an engine and a generator, acting as a motor, whereby generator torque assists the engine to develop a stable running speed throughout an engine start event, particularly a cold engine start event, without violating battery power limits.
    Type: Application
    Filed: December 4, 2007
    Publication date: June 4, 2009
    Applicant: FORD GLOBAL TECHNOLOGIES, LLC
    Inventors: Paul Stephen Bryan, Christopher Adam Ochocinski, Kenneth Frederick, Shunsuke Okubo
  • Publication number: 20090105037
    Abstract: Inverters of a hybrid electric vehicle are cooled by a coolant. Expected temperature differences between the inverters and the coolant are determined based on vehicle parameters. Actual temperature differences between the inverters and the coolant are compared to the expected temperature differences. A maximum output torque is reduced if the actual temperature differences exceed the expected temperature differences.
    Type: Application
    Filed: October 23, 2007
    Publication date: April 23, 2009
    Applicant: FORD GLOBAL TECHNOLOGIES, LLC
    Inventors: Khang Thanh Hong, William David Treharne, Paul Stephen Bryan, Shunsuke Okubo
  • Patent number: 7482487
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Grant
    Filed: March 10, 2005
    Date of Patent: January 27, 2009
    Assignee: Pfizer Inc
    Inventors: Alan Daniel Brown, Justin Stephen Bryans, Paul Alan Glossop, Charlotte Alice Louise Lane, Simmon John Mantell
  • Publication number: 20080307811
    Abstract: The embodiments described herein include a control system and method for a compressor that is operable with a climate system. The control system enables optimal climate system operation by efficiently controlling the operating speed of the compressor.
    Type: Application
    Filed: June 12, 2007
    Publication date: December 18, 2008
    Applicant: FORD GLOBAL TECHNOLOGIES, LLC
    Inventors: Paul Stephen Bryan, Matthew D. Smith, William David Treharne, Susan Rebecca Cikanek
  • Patent number: 7442795
    Abstract: A compound of formula (I), or a pharmaceutically acceptable derivative, wherein A, B, V, W, X, Y, and Z are as defined herein; pharmaceutical compositions thereof; and uses thereof.
    Type: Grant
    Filed: May 1, 2006
    Date of Patent: October 28, 2008
    Assignee: Pfizer Inc.
    Inventors: Justin Stephen Bryans, Patrick Stephen Johnson, Thomas Ryckmans, Alan Stobie
  • Publication number: 20080234252
    Abstract: Compounds of formula (I), or a pharmaceutically acceptable salt, solvate, ester or amide thereof, wherein R1 represents [CH2]n—R2.
    Type: Application
    Filed: May 8, 2006
    Publication date: September 25, 2008
    Inventors: Justin Stephen Bryans, Patrick Stephen Johnson, Lee Richard Roberts, Thomas Ryckmans
  • Publication number: 20080188478
    Abstract: Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents a group selected from H, CF3, and C1-6 alkyl (optionally substituted by C1-6 alkyloxy or triazolyl); R2 represents halo; Ring A represents a 5- or 6-membered heterocyclic ring containing at least one N atom (the ring being optionally bridged with two or more carbon atoms); R3 represents a 5- or 6-membered heterocyclic ring containing at least one atom selected from N, O or S, the heterocyclic ring being optionally substituted by one or more groups selected from C1-6 alkyl oxo or NH2, the heterocyclic ring being further optionally fused to a 5- or 6-membered aryl or heterocyclic ring containing at least one atom selected from N, O or S, the fused aryl or heterocyclic ring being substituted by one or more halo atoms; are useful for treating a disorder for which a V1a antagonist is indicated, in particular, dysmenorrhea.
    Type: Application
    Filed: April 18, 2006
    Publication date: August 7, 2008
    Inventors: Justin Stephen Bryans, Mark Edward Bunnage, Patrick Stephen Johnson, Helen Janet Mason, Lee Richard Roberts, Thomas Ryckmans, Alan Stobie, Toby James Underwood
  • Patent number: 7183294
    Abstract: The invention relates to indole derivatives and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The indole derivatives according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: February 27, 2007
    Assignee: Pfizer Inc.
    Inventors: Alan Daniel Brown, Justin Stephen Bryans, Mark Edward Bunnage, Paul Alan Glossop, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite, Simon John Mantell
  • Patent number: 7141606
    Abstract: The invention provides a new use of compounds for formula 1 or 1A or a pharmaceutically acceptable salt thereof. The compounds are useful in the treatment of insomnia and related disorders.
    Type: Grant
    Filed: May 18, 2001
    Date of Patent: November 28, 2006
    Assignee: Warner-Lambert Company
    Inventors: Justin Stephen Bryans, Leonard Theodore Meltzer
  • Patent number: 7138527
    Abstract: The invention relates to indole derivatives and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The indole derivatives according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Grant
    Filed: October 5, 2004
    Date of Patent: November 21, 2006
    Assignee: Pfizer Inc.
    Inventors: Alan Daniel Brown, Justin Stephen Bryans, Mark Edward Bunnage, Paul Alan Glossop, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite, Simon Mantell
  • Patent number: 7122678
    Abstract: The invention is a novel series of cyclic amino acids which are useful in the treatment of epilepsy, faintness attacks, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, gastrointestinal disorders such as irritable bowel syndrome (IBS), and inflammation, especially arthritis. A pharmaceutical composition containing a compound of the invention as well as methods of preparing the compounds and novel intermediates useful in the preparation of the final compounds are included.
    Type: Grant
    Filed: March 11, 2005
    Date of Patent: October 17, 2006
    Assignee: Warner-Lambert Company
    Inventors: Justin Stephen Bryans, David Christopher Horwell, Andrew John Thorpe, David Juergen Wustrow, Po-Wai Yuen
  • Patent number: 7119088
    Abstract: A compound of formula (I), or a pharmaceutically acceptable derivative thereof, wherein A, B, V, W, X, Y, and Z are as defined herein; pharmaceutical compositions thereof; and uses thereof.
    Type: Grant
    Filed: February 18, 2004
    Date of Patent: October 10, 2006
    Assignee: Pfizer Inc.
    Inventors: Justin Stephen Bryans, Patrick Stephen Johnson, Thomas Ryckmans, Alan Stobie
  • Patent number: 7084145
    Abstract: The invention provides compounds of formula (I), the pharmaceutically acceptable salts and solvates thereof, wherein A, B, R1, R2, and R7 are as defined herein; pharmaceutical compositions thereof; combinations thereof; and uses thereof as vasopressin V1A antagonists.
    Type: Grant
    Filed: October 24, 2003
    Date of Patent: August 1, 2006
    Assignee: Pfizer Inc.
    Inventors: Robert Duncan Armour, Andrew Douglas Baxter, Justin Stephen Bryans, Kevin Neil Dack, Patrick Stephen Johnson, Russell Andrew Lewthwaite, Julie Newman, David James Rawson, Thomas Ryckmans
  • Patent number: 7067541
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Grant
    Filed: June 3, 2004
    Date of Patent: June 27, 2006
    Assignee: Pfizer Inc
    Inventors: Alan Daniel Brown, Justin Stephen Bryans, Charlotte Alice Louise Lane, Simon John Mantell